EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center

Iwona Swiatkiewicz iD, Neeja T Patel, MaryAnn Villarreal-Gonzalez, Pam R Taub

BMC Medicine · 14.05.2024 · 22 (1)

DOI: 10.1186/s12916-024-03401-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Medicine, online erschienen am 14.05.2024. Verfasst von Iwona Swiatkiewicz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, 92037, USA. iswiatkiewicz@health.ucsd.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Cardiomyopathies, Academic Medical Centers. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic cardiomyopathy (DbCM) is characterized by asymptomatic stage B heart failure (SBHF) caused by diabetes-related metabolic alterations. DbCM is associated with an increased risk of progression to overt heart failure (HF). The prevalence of DbCM in patients with type 2 diabetes (T2D) is not well established. This study aims to determine prevalence of DbCM in adult T2D patients in real-world clinical practice.

Methods

Retrospective multi-step review of electronic medical records of patients with the diagnosis of T2D who had echocardiogram at UC San Diego Medical Center (UCSD) within 2010–2019 was conducted to identify T2D patients with SBHF. We defined “pure” DbCM when SBHF is associated solely with T2D and “mixed” SBHF when other medical conditions can contribute to SBHF. “Pure” DbCM was diagnosed in T2D patients with echocardiographic demonstration of SBHF defined as left atrial (LA) enlargement (LAE), as evidenced by LA volume index ≥ 34 mL/m 2 , in the presence of left ventricular ejection fraction (LVEF) ≥ 45%, while excluding overt HF and comorbidities that can contribute to SBHF.

Results

Of 778,314 UCSD patients in 2010–2019, 45,600 (5.9%) had T2D diagnosis. In this group, 15,182 T2D patients (33.3%) had echocardiogram and, among them, 13,680 (90.1%) had LVEF ≥ 45%. Out of 13,680 patients, 4,790 patients had LAE. Of them, 1,070 patients were excluded due to incomplete data and/or a lack of confirmed T2D according to the American Diabetes Association recommendations. Thus, 3,720 T2D patients with LVEF ≥ 45% and LAE were identified, regardless of HF symptoms. In this group, 1,604 patients (43.1%) had overt HF and were excluded. Thus, 2,116 T2D patients (56.9% of T2D patients with LVEF ≥ 45% and LAE) with asymptomatic SBHF were identified. Out of them, 1,773 patients (83.8%) were diagnosed with “mixed” SBHF due to comorbidities such as hypertension (58%), coronary artery disease (36%), and valvular heart disease (17%). Finally, 343 patients met the diagnostic criteria of “pure” DbCM, which represents 16.2% of T2D patients with SBHF, i.e., at least 2.9% of the entire T2D population in this study.

Conclusions

Our findings provide insights into prevalence of DbCM in real-world clinical practice and indicate that DbCM affects a significant portion of T2D patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic CardiomyopathiesAcademic Medical CentersHumansMaleFemaleMiddle AgedRetrospective StudiesPrevalenceAgedEchocardiographyAdultHeart Failure

Stichwörter der Autor:innen

ComorbiditiesDiabetesDiabetic cardiomyopathyEchocardiographyHeart failureOutcome

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, 92037, USA. iswiatkiewicz@health.ucsd.edu.
  • Division of Cardiovascular Medicine, University of California San Diego, La Jolla, CA, 92037, USA.

ORCID-Profile: Iwona Swiatkiewicz

Förderung

  • Applied Therapeutics

Zitieren

APA

Swiatkiewicz, I., Patel, N. T., Villarreal-Gonzalez, M., & Taub, P. R. (2024). Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Medicine, 22(1). https://doi.org/10.1186/s12916-024-03401-3

Vancouver

Swiatkiewicz I, Patel NT, Villarreal-Gonzalez M, Taub PR. Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center. BMC Medicine. 2024;22(1). doi:10.1186/s12916-024-03401-3

BibTeX
@article{Swiatkiewicz2024,
  author = {Swiatkiewicz, Iwona and Patel, Neeja T and Villarreal-Gonzalez, MaryAnn and Taub, Pam R},
  title = {Prevalence of diabetic cardiomyopathy in patients with type 2 diabetes in a large academic medical center},
  journal = {BMC Medicine},
  year = {2024},
  volume = {22},
  number = {1},
  doi = {10.1186/s12916-024-03401-3}
}
Kostenlos starten →